Hi Sarah,
I wanted to flag a budget vs. actual variance identified in Finance Intelligence for FY2026 YTD:
• Eliquis (EMEA): Actual $9.6M vs Budget $12.8M → −$3.2M (−25%)
• Xeljanz (APAC): Actual $6.5M vs Budget $8.4M → −$1.9M (−23%)
Root cause: Both products had zero sales entered in Lighthouse despite units being available, resulting in an under-budgeted baseline of −$5.1M.
I have opened a correction request in Lighthouse (pre-filtered to affected products). Please review and approve the reforecast at your earliest convenience.
Happy to walk through the details — let me know.
Best regards
How can I help you today?
Suggested prompts
Give the latest Product Masterdata after the re-org
Create a new WBS in Budget form for Comm. Primary Care
Top 3 products with highest revenue variance vs budget in 2026
Update my security profile for market 8191 in POD and Mosaic